Moreover, TRAIL treatment alone did not induce any morphological changes in HCC-15 and Calu-3 cells compared with those in control cells, indicating that these cells were highly resistant to TRAIL. The gene discussed is TNFSF10; the disease is hepatocellular carcinoma.